Ariel Linden
Linden Consulting Group, LLC
Maximizing the discriminatory accuracy of a diagnostic or screening test is paramount to ensuring that individuals with or without the disease (or disease marker) are correctly identified as such. In this paper, I describe how the new Stata package for implementing ODA can be used to determine the optimal cut-point along the continuum of test values that maximally discriminates between those with and without the disease.
odajournal.com 